Michael G. Rosenblum
Affiliations: | University of Texas, MD Anderson Cancer Center |
Website:
https://www.mdanderson.org/research/departments-labs-institutes/labs/rosenblum-lab/lab-members.htmlGoogle:
"Michael Gordon Rosenblum"Bio:
https://books.google.com/books?id=giEoAQAAIAAJ
Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Diane Haddock Russell | grad student | 1978 | University of Arizona | |
| (Distribution, metabolism, and excretion of polyamines in rats and humans.) | ||||
Children
Sign in to add trainee| Yu Joshua Cao | grad student | 2007-2013 | University of Texas, MD Anderson Cancer Center |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Alvarez de Cienfuegos A, Cheung LH, Mohamedali KA, et al. (2020) Therapeutic efficacy and safety of a human fusion construct targeting the TWEAK receptor Fn14 and containing a modified granzyme B. Journal For Immunotherapy of Cancer. 8 |
| Brown K, Meader L, Nowocin A, et al. (2020) A novel in vivo model using immunotoxin in the absence of p-glycoprotein to achieve ultra selective depletion of target cells: Applications in trogocytosis and beyond. Journal of Immunological Methods. 112794 |
| Mohamedali KA, Cheung LH, Alvarez-Cienfuegos AA, et al. (2020) Abstract 5194: Development of a cytotoxic fusion protein targeting VEGF receptors with improved cytotoxicity, stability and pharmacokinetics Cancer Research. 80: 5194-5194 |
| Mohamedali KA, Su-yin K, Cheung LH, et al. (2020) Abstract 2891: Targeting breast cancer stem cells with anti-EMP2 immunotoxins delivering granzyme b Cancer Research. 80: 2891-2891 |
| Olsen CE, Cheung LH, Weyergang A, et al. (2019) Design, Characterization, and Evaluation of scFvCD133/rGelonin: A CD133-Targeting Recombinant Immunotoxin for Use in Combination with Photochemical Internalization. Journal of Clinical Medicine. 9 |
| Cheung LH, Zhao Y, Alvarez-Cienfuegos A, et al. (2019) Development of a human immuno-oncology therapeutic agent targeting HER2: targeted delivery of granzyme B. Journal of Experimental & Clinical Cancer Research : Cr. 38: 332 |
| Mohamedali KA, Cheung LH, Alvarez-Cienfuegos A, et al. (2019) Abstract 2396: Development of a new generation of dimeric, highly cytotoxic fusion proteins containing active GrB and VEGF targeting tumor neovasculature: Incorporating IgG heavy chain Fc fragments improves cytotoxicity, stability and pharmacokinetics Cancer Research. 79: 2396-2396 |
| Weyergang A, Fremstedal AS, Skarpen E, et al. (2018) Light-enhanced VEGF/rGel: A tumor targeted modality with vascular and immune-mediated efficacy. Journal of Controlled Release : Official Journal of the Controlled Release Society |
| Eng MS, Kaur J, Prasmickaite L, et al. (2018) Enhanced targeting of triple-negative breast carcinoma and malignant melanoma by photochemical internalization of CSPG4-targeting immunotoxins. Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society For Photobiology. 17: 539-551 |
| Mohamedali KA, Cheung LH, Rosenblum MG. (2018) Abstract 4182: Impacting early events in metastatic spread: Targeted therapeutics to disrupt formation of the pre-metastatic niche and development of lung metastases Cancer Research. 78: 4182-4182 |